Literature DB >> 9722811

Syringe exchange programs: lowering the transmission of syringe-borne diseases and beyond.

R Heimer1.   

Abstract

OBJECTIVE: This chapter attempts to describe the factors influencing the transmission of syringe-born viruses, to review the effects of syringe exchange programs (SEPs) in terms of these factors, and to explore the gamut of health-promoting activities of SEPs.
RESULTS: The chapter is divided into six sections: biological factors in syringe-borne viral transmission, behavior and viral transmission, quantifying viral transmission, preventing viral transmission, impediments to preventing viral transmission, and research for preventing viral transmission. Understanding how biological and behavioral factors influence transmission of human immunodeficiency virus (HIV) and hepatitis builds a framework to investigate the epidemiology and the impact of SEPs on disease transmission. Even under circumstances in which these programs do not appear to be effective, understanding the implications of the biological and behavioral factors can contribute to our understanding of program benefits and limitations. Furthermore, program benefits may not be restricted to direct effects on disease transmission. Many programs offer services to drug injectors that include risk reduction training, facilitated entry into substance abuse treatment, and medical care.
CONCLUSIONS: SEPs can reduce the transmission of syringe-borne viruses without increasing illicit drug use. However, lack of resources, acceptance, and consequently, protection of many of those at risk when they are most vulnerable have hampered program effectiveness. New studies need to be designed to explicate the full measure of program benefit within covered communities and identify the means by which SEPs can expand benefit to individuals at greatest risk.

Entities:  

Mesh:

Year:  1998        PMID: 9722811      PMCID: PMC1307728     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  41 in total

1.  Update: syringe-exchange programs--United States, 1996.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1997-06-20       Impact factor: 17.586

2.  Needle exchange is not enough: lessons from the Vancouver injecting drug use study.

Authors:  S A Strathdee; D M Patrick; S L Currie; P G Cornelisse; M L Rekart; J S Montaner; M T Schechter; M V O'Shaughnessy
Journal:  AIDS       Date:  1997-07       Impact factor: 4.177

3.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

4.  Invited commentary: le mystère de Montréal.

Authors:  P Lurie
Journal:  Am J Epidemiol       Date:  1997-12-15       Impact factor: 4.897

5.  Prevention of HIV/AIDS and other blood-borne diseases among injection drug users. A national survey on the regulation of syringes and needles.

Authors:  L O Gostin; Z Lazzarini; T S Jones; K Flaherty
Journal:  JAMA       Date:  1997-01-01       Impact factor: 56.272

6.  An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA.

Authors:  P Lurie; E Drucker
Journal:  Lancet       Date:  1997-03-01       Impact factor: 79.321

7.  High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: results of a cohort study.

Authors:  J Bruneau; F Lamothe; E Franco; N Lachance; M Désy; J Soto; J Vincelette
Journal:  Am J Epidemiol       Date:  1997-12-15       Impact factor: 4.897

8.  Needles that kill: modeling human immunodeficiency virus transmission via shared drug injection equipment in shooting galleries.

Authors:  E H Kaplan
Journal:  Rev Infect Dis       Date:  1989 Mar-Apr

Review 9.  The role of needle exchange programs in HIV prevention.

Authors:  D Vlahov; B Junge
Journal:  Public Health Rep       Date:  1998-06       Impact factor: 2.792

10.  Risk factors for human immunodeficiency virus infection in intravenous drug users.

Authors:  E E Schoenbaum; D Hartel; P A Selwyn; R S Klein; K Davenny; M Rogers; C Feiner; G Friedland
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

View more
  15 in total

1.  Survival of hepatitis C virus in syringes: implication for transmission among injection drug users.

Authors:  Elijah Paintsil; Huijie He; Christopher Peters; Brett D Lindenbach; Robert Heimer
Journal:  J Infect Dis       Date:  2010-10-01       Impact factor: 5.226

2.  Inactivation and survival of hepatitis C virus on inanimate surfaces.

Authors:  Juliane Doerrbecker; Martina Friesland; Sandra Ciesek; Thomas J Erichsen; Pedro Mateu-Gelabert; Jörg Steinmann; Jochen Steinmann; Thomas Pietschmann; Eike Steinmann
Journal:  J Infect Dis       Date:  2011-10-19       Impact factor: 5.226

Review 3.  Epidemiology of HIV/AIDS, hepatitis B, hepatitis C, and tuberculosis among minority injection drug users.

Authors:  Antonio L Estrada
Journal:  Public Health Rep       Date:  2002       Impact factor: 2.792

Review 4.  Needle syringe programmes and opioid substitution therapy for preventing hepatitis C transmission in people who inject drugs.

Authors:  Lucy Platt; Silvia Minozzi; Jennifer Reed; Peter Vickerman; Holly Hagan; Clare French; Ashly Jordan; Louisa Degenhardt; Vivian Hope; Sharon Hutchinson; Lisa Maher; Norah Palmateer; Avril Taylor; Julie Bruneau; Matthew Hickman
Journal:  Cochrane Database Syst Rev       Date:  2017-09-18

5.  Injection risk behaviors among rural drug users: implications for HIV prevention.

Authors:  Jennifer R Havens; Carrie B Oser; Carl G Leukefeld
Journal:  AIDS Care       Date:  2011-05

6.  Expanding harm reduction services through a wound and abscess clinic.

Authors:  Lauretta E Grau; Silvia Arevalo; Christopher Catchpool; Robert Heimer
Journal:  Am J Public Health       Date:  2002-12       Impact factor: 9.308

Review 7.  Progress in HIV reduction and prevention among injection and noninjection drug users.

Authors:  Natalie D Crawford; David Vlahov
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

8.  Risk-taking behaviors among injecting drug users who obtain syringes from pharmacies, fixed sites, and mobile van needle exchanges.

Authors:  Cari L Miller; Mark Tyndall; Patricia Spittal; Kathy Li; Anita Palepu; Martin T Schechter
Journal:  J Urban Health       Date:  2002-06       Impact factor: 3.671

9.  Negotiating access: social barriers to purchasing syringes at pharmacies in Tijuana, Mexico.

Authors:  Peter J Davidson; Remedios Lozada; Perth C Rosen; Armando Macias; Manuel Gallardo; Robin A Pollini
Journal:  Int J Drug Policy       Date:  2012-06-05

10.  High dead-space syringes and the risk of HIV and HCV infection among injecting drug users.

Authors:  William A Zule; Georgiy Bobashev
Journal:  Drug Alcohol Depend       Date:  2008-11-11       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.